Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 20, Issue 11, 2014, Pages 1203-1208

  Kandiah, Nagaendran ^a,b   Zainal, Nur Hani ^a   Narasimhalu, Kaavya ^a   Chander, Russell Jude ^a   Ng, Aloysius ^a   Mak, Elijah ^a   Au, Wing Lok ^a,b   Sitoh, Yih Yian ^a,b   Nadkarni, Nivedita ^c   Tan, Louis C S ^a,b  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cerebrovascular disease; Cognition; Hippocampus; MRI; Parkinson's disease

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; APOE4 GENE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DEMENTIA; DEPTH PERCEPTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EPISODIC MEMORY; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; GENE FREQUENCY; GENERAL PATHOLOGICAL PARAMETERS; HIPPOCAMPUS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MOVEMENT DISORDER SOCIETY CRITERION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PREDICTIVE VALUE; PROSPECTIVE STUDY; RADIATION RELATED PHENOMENA; RISK FACTOR; SURVIVAL RATE; TERTIARY CARE CENTER; TIME TO COGNITIVE IMPAIRMENT; WHITE MATTER DISEASE; WHITE MATTER HYPERINTENSITY; WORKING MEMORY; COMPLICATION; KAPLAN MEIER METHOD; LEUKOENCEPHALOPATHIES; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; DEMENTIA; FEMALE; HIPPOCAMPUS; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOENCEPHALOPATHIES; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; SEVERITY OF ILLNESS INDEX;

EID: 84908572970     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.08.024     Document Type: Article

References (30)

1. Hilker R., Thomas A.V., Klein J.C., Weisenbach S., Kalbe E., Burghaus L., et al. Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 2005, 65(11):1716-1722.
2. Aarsland D., Andersen K., Larsen J.P., Lolk A., Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003, 60(3):387-392.
3. Schrag A., Selai C., Jahanshahi M., Quinn N.P. The EQ-5D-a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatr 2000, 69(1):67-73.
4. Bohnen N.I., Kaufer D.I., Ivanco L.S., Lopresti B., Koeppe R.A., Davis J.G., et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 2003, 60:1745-1748.
5. Svenningsson P., Westman E., Ballard C., Aarsland D. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol 2012 Aug, 11(8):697-707.
6. Owen A.M., James M., Leigh P.N., Summers B.A., Marsden C.D., Quinn N.P., et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992 Dec, 115(Pt 6):1727-1751.
7. Kandiah N., Mak E., Ng A., Huang S., Au W.L., Sitoh Y.Y., et al. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment. Parkinsonism Relat Disord 2013 Jul, 19(7):680-683.
8. González-Redondo R., Toledo J., Clavero P., Lamet I., García- García D., García-Eulate R., et al. The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease. Eur J Neurol 2012, 19:1100-1107.
9. Dalaker T.O., Larsen J.P., Dwyer M.G., Aarsland D., Beyer M.K., Alves G., et al. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease. Neuroimage 2009, 47:2083-2089.
10. Haugarvoll K., Aarsland D., Wentzel-Larsen T., Larsen J.P. The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease. Acta Neurol Scand 2005, 112:386-390.
11. Goldman J.G., Stebbins G.T., Bernard B., Stoub T.R., Goetz C.G., deToledo-Morrell L. Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia. Mov Disord 2012 May, 27(6):727-734.
12. Zhang Y., Zhang J., Xu J., Wu X., Zhang Y., Feng H., et al. Cortical gyrification reductions and subcortical atrophy in Parkinson's disease. Mov Disord 2014 Jan, 29(1):122-126.
13. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson's disease. Arch Neurol 1999, 56(1):33-39.
14. Goetz C.G., Tilley B.C., Shaftman S.R., Stebbins G.T., Fahn S., Martinez-Martin P., et al. Movement disorder society-sponsored revision of the unified Parkinsons disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008, 23(15):2129-2170.
15. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinicians. J Psychiatr Res 1975, 12(3):189-198.
16. Nasreddine Z.S., Phillips N.A., Bedirian V., Charbonneau S., Whitehead V., Collin I., et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005, 53(4):695-699.
17. Dubois B., Slachevsky A., Litvan I., Pillon B. F.A.B. The, A frontal assessment battery at bedside. Neurology 2000, 55(11):1621-1626.
18. Sunderland T., Hill J.L., Mellow A.M., Lawlor B.A., Gundersheimer J., Newhouse P.A., et al. Clock drawing in Alzheimer's disease: a novel measure of dementia severity. J Am Geriatr Soc 1989, 37(8):,725-729.
19. Sheikh J.I., Yesavage J.A. Geriatric depression scale (GDS). Recent evidence and development of a shorter version. Clinical gerontology: a guide to assessment and intervention 1986, 165-173. The Haworth Press, Inc, New York. T.L. Brink (Ed.).
20. Patenaude B., Smith S.M., Kennedy D., Jenkinson M.A. Bayesian model of shape and appearance for subcortical brain. NeuroImage 2011, 56:907-922.
21. Morey R.A., Petty C.M., Xu Y., Hayes J.P., Wagner H.R., Lewis D.V., et al. A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes. NeuroImage 2009, 45:855-866.
22. Firbank M.J., Minett T., O'Brien J.T. Changes in DWI and MRS associated withwhite matter hyperintensities in elderly subjects. Neurology 2003, 61:950-954.
23. Litvan I., Goldman J.G., Tröster A.I., Schmand B.A., Weintraub D., Petersen R.C., et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines. Mov Disord 2012, 27(3):349-356.
24. Emre M., Aarsland D., Brown R., Burn D.J., Duyckaerts C., Mizuno Y., et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007, 22:1689-1707.
25. Smith E.E., Egorova S., Blacker D., Killiany R.J., Muzikansky A., Dickerson B.C., et al. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol 2008 Jan, 65(1):94-100.
26. van de Pol L.A., Hensel A., van der Flier W.M., Visser P.J., Pijnenburg Y.A., Barkhof F., et al. Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease. J Neurol Neurosurg Psychiatr 2006 Apr, 77(4):439-442.
27. Donix M., Scharf M., Marschner K., Werner A., Sauer C., Gerner A., et al. Cardiovascular risk and hippocampal thickness in Alzheimer's disease. Int J Alzheimers Dis 2013, 2013:108021.
28. Savica R., Grossardt B.R., Bower J.H., Boeve B.F., Ahlskog J.E., Rocca W.A. Incidence of dementia with lewy bodies and parkinson disease dementia. JAMA Neurol 2013 Sep 16, 70(11):1396-1402.
29. Camicioli R., Moore M.M., Kinney A., Corbridge E., Glassberg K., Kaye J.A. Parkinson's disease is associated with hippocampal atrophy. Mov Disord 2003, 18:784-790.
30. Shin J., Choi S., Lee J.E., Lee H.S., Sohn Y.H., Lee P.H. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status. J Neurol Neurosurg Psychiatr 2012 Mar, 83(3):315-321.